Works in European Journal of Nuclear Medicine & Molecular Imaging, 2019, Vol 46, Issue 7

Results: 26

Adrenal tracer uptake by 18F-FDOPA PET/CT in patients with pheochromocytoma and controls.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1560, doi. 10.1007/s00259-019-04332-5

By:

Noordzij, Walter;
Glaudemans, Andor W. J. M.;
Schaafsma, Mirte;
van der Horst-Schrivers, Anouk N. A.;
Slart, Riemer H. J. A.;
van Beek, André P.;
Kerstens, Michiel N.

Publication type:

Article

Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment.

Published in:

2019

By:

Costa, Larissa Bastos;
Queiroz, Marcelo Araujo;
Barbosa, Felipe de Galiza;
Nunes, Rafael Fernandes;
Marin, José Flávio Gomes;
Dzik, Carlos;
Buchpiguel, Carlos Alberto

Publication type:

Case Study

EANM Focus 1: one small step for two men, one giant leap for a specialty.

Published in:

2019

By:

Fanti, Stefano;
Oyen, Wim J. G.

Publication type:

Proceeding

Time for new imaging and therapeutic approaches in cardiac amyloidosis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1402, doi. 10.1007/s00259-019-04325-4

By:

Slart, Riemer H. J. A.;
Glaudemans, Andor W. J. M.;
Noordzij, Walter;
Bijzet, Johan;
Hazenberg, Bouke P. C.;
Nienhuis, Hans L. A.

Publication type:

Article

Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.

Published in:

2019

By:

Humbert, Olivier;
Bourg, Véronique;
Mondot, Lydiane;
Gal, Jocelyn;
Bondiau, Pierre-Yves;
Fontaine, Denys;
Barriere, Jérôme;
Saada-Bouzid, Esma;
Paquet, Marie;
Chardin, David;
Almairac, Fabien;
Vandenbos, Fanny;
Darcourt, Jacques

Publication type:

Correction Notice

Diagnostic performance of 68Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1531, doi. 10.1007/s00259-019-04320-9

By:

Gao, Jie;
Zhang, Chengwei;
Zhang, Qing;
Fu, Yao;
Zhao, Xiaozhi;
Chen, Mengxia;
Zhang, Bing;
Li, Danyan;
Shi, Jiong;
Wang, Feng;
Guo, Hongqian

Publication type:

Article

PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1468, doi. 10.1007/s00259-019-04313-8

By:

Antunovic, Lidija;
De Sanctis, Rita;
Cozzi, Luca;
Kirienko, Margarita;
Sagona, Andrea;
Torrisi, Rosalba;
Tinterri, Corrado;
Santoro, Armando;
Chiti, Arturo;
Zelic, Renata;
Sollini, Martina

Publication type:

Article

Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1417, doi. 10.1007/s00259-019-04309-4

By:

Shagera, Qaid Ahmed;
Cheon, Gi Jeong;
Koh, Youngil;
Yoo, Min Young;
Kang, Keon Wook;
Lee, Dong Soo;
Kim, E. Edmund;
Yoon, Sung-Soo;
Chung, June-Key

Publication type:

Article

Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1542, doi. 10.1007/s00259-019-04308-5

By:

Sawicki, Lino M.;
Kirchner, Julian;
Buddensieck, Carolin;
Antke, Christina;
Ullrich, Tim;
Schimmöller, Lars;
Boos, Johannes;
Schleich, Christoph;
Schaarschmidt, Benedikt M.;
Buchbender, Christian;
Heusch, Philipp;
Rabenalt, Robert;
Albers, Peter;
Antoch, Gerald;
Müller, Hans-Wilhelm;
Hautzel, Hubertus

Publication type:

Article

Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1485, doi. 10.1007/s00259-019-04307-6

By:

Hofheinz, Frank;
Li, Yimin;
Steffen, Ingo G.;
Lin, Qin;
Lili, Chen;
Hua, Wu;
van den Hoff, Jörg;
Zschaeck, Sebastian

Publication type:

Article

Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1478, doi. 10.1007/s00259-019-04306-7

By:

Baiocco, Serena;
Sah, Bert-Ram;
Mallia, Andrew;
Kelly-Morland, Christian;
Neji, Radhouene;
Stirling, J. James;
Jeljeli, Sami;
Bevilacqua, Alessandro;
Cook, Gary J. R.;
Goh, Vicky

Publication type:

Article

Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1397, doi. 10.1007/s00259-019-04304-9

By:

Ell, Peter;
Carrio, Ignasi;
Chiti, Arturo

Publication type:

Article

18F-FDG uptake of brown fat and cancer: casualty or causality?

Published in:

2019

By:

Gennaro, Nicolò;
Pepe, Giovanna;
Antunovic, Lidija

Publication type:

Letter to the Editor

Clinical utility of 68Ga-DOTATOC positron emission tomography/computed tomography for recurrent renal cell carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1524, doi. 10.1007/s00259-019-04298-4

By:

Nakamoto, Yuji;
Ishimori, Takayoshi;
Shimizu, Yoichi;
Sano, Kohei;
Togashi, Kaori

Publication type:

Article

18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1518, doi. 10.1007/s00259-019-04295-7

By:

Toriihara, Akira;
Duan, Heying;
Thompson, Holly M.;
Park, Sonya;
Hatami, Negin;
Baratto, Lucia;
Fan, Alice C.;
Iagaru, Andrei

Publication type:

Article

One-stop shopping 18F-FDG PET/CT in a patient with vascular type Behçet's disease.

Published in:

2019

By:

Norikane, Takashi;
Yamamoto, Yuka;
Takami, Yasukage;
Mitamura, Katsuya;
Arai-Okuda, Hanae;
Nishiyama, Yoshihiro

Publication type:

Case Study

TSH suppression aggravates arterial inflammation — an 18F-FDG PET study in thyroid carcinoma patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1428, doi. 10.1007/s00259-019-04292-w

By:

Boswijk, Ellen;
Sanders, Karin J. C.;
Broeders, Evie P. M.;
de Ligt, Marlies;
Vijgen, Guy H. E. J.;
Havekes, Bas;
Mingels, Alma M. A.;
Wierts, Roel;
van Marken Lichtenbelt, Wouter D.;
Schrauwen, Patrick;
Mottaghy, Felix M.;
Wildberger, Joachim E.;
Bucerius, Jan

Publication type:

Article

Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1567, doi. 10.1007/s00259-019-04291-x

By:

Genolla, Jose;
Rodriguez, Trinidad;
Minguez, Pablo;
Lopez-Almaraz, Ricardo;
Llorens, Veronica;
Echebarria, Aizpea

Publication type:

Article

Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1407, doi. 10.1007/s00259-019-04290-y

By:

Kircher, Malte;
Ihne, Sandra;
Brumberg, Joachim;
Morbach, Caroline;
Knop, Stefan;
Kortüm, K. Martin;
Störk, Stefan;
Buck, Andreas K.;
Reiter, Theresa;
Bauer, Wolfgang R.;
Lapa, Constantin

Publication type:

Article

Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1457, doi. 10.1007/s00259-019-04287-7

By:

Yang, Min-Fu;
Tong, Zhao-Hui;
Wang, Zhen;
Zhang, Ying-Yi;
Xu, Li-Li;
Wang, Xiao-Juan;
Li, Wan;
Wu, Xiu-Zhi;
Wang, Wen;
Zhang, Yu-Hui;
Jiang, Tao;
Shi, Huan-Zhong

Publication type:

Article

Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up].

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1448, doi. 10.1007/s00259-019-04285-9

By:

Vera, Pierre;
Mihailescu, Sorina-Dana;
Lequesne, Justine;
Modzelewski, Romain;
Bohn, Pierre;
Hapdey, Sébastien;
Pépin, Louis-Ferdinand;
Dubray, Bernard;
Chaumet-Riffaud, Philippe;
Decazes, Pierre;
Thureau, Sébastien

Publication type:

Article

Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1495, doi. 10.1007/s00259-019-04284-w

By:

Ankersmit, M.;
Hoekstra, O. S.;
van Lingen, A.;
Bloemena, E.;
Jacobs, M. A. J. M.;
Vugts, D. J.;
Bonjer, H. J.;
van Dongen, G. A. M. S.;
Meijerink, W. J. H. J.

Publication type:

Article

Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1506, doi. 10.1007/s00259-019-04277-9

By:

Delaunay, Kostas;
Edeline, Julien;
Rolland, Yan;
Lepareur, Nicolas;
Laffont, Sophie;
Palard, Xavier;
Bouvry, Christelle;
Le Sourd, Samuel;
Pracht, Marc;
Ardisson, Valérie;
Noiret, Nicolas;
Bellissant, Éric;
Garin, Etienne

Publication type:

Article

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1439, doi. 10.1007/s00259-019-4270-x

By:

Guberina, Maja;
Eberhardt, Wilfried;
Stuschke, Martin;
Gauler, Thomas;
Aigner, Clemens;
Schuler, Martin;
Stamatis, Georgios;
Theegarten, Dirk;
Jentzen, Walter;
Herrmann, Ken;
Pöttgen, Christoph

Publication type:

Article

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1399, doi. 10.1007/s00259-018-4243-5

By:

Elsinga, Philip;
Delaloye, Angelika Bischof;
Chiti, Arturo;
Vandenberghe, Stefaan;
Giammarile, Francesco;
Carrio, Ignasi

Publication type:

Article

Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1551, doi. 10.1007/s00259-018-4219-5

By:

Voglimacci, Marie;
Gabiache, Erwan;
Lusque, Amélie;
Ferron, Gwenaël;
Ducassou, Anne;
Querleu, Denis;
Motton, Stéphanie;
Chantalat, Elodie;
Courbon, Frédéric;
Martinez, Alejandra

Publication type:

Article

Works in European Journal of Nuclear Medicine & Molecular Imaging, 2019, Vol 46, Issue 7

Adrenal tracer uptake by <sup>18</sup>F-FDOPA PET/CT in patients with pheochromocytoma and controls.

Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment.

EANM Focus 1: one small step for two men, one giant leap for a specialty.

Time for new imaging and therapeutic approaches in cardiac amyloidosis.

Correction to: <sup>18</sup>F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.

Diagnostic performance of <sup>68</sup>Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections.

PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.

Prognostic value of metabolic tumour volume on baseline <sup>18</sup>F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Prospective comparison of whole-body MRI and <sup>68</sup>Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.

Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.

Exploratory radiomic features from integrated <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer.

Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit.

<sup>18</sup>F-FDG uptake of brown fat and cancer: casualty or causality?

Clinical utility of <sup>68</sup>Ga-DOTATOC positron emission tomography/computed tomography for recurrent renal cell carcinoma.

<sup>18</sup>F-FPPRGD<sub>2</sub> PET/CT in patients with metastatic renal cell cancer.

One-stop shopping <sup>18</sup>F-FDG PET/CT in a patient with vascular type Behçet's disease.

TSH suppression aggravates arterial inflammation — an <sup>18</sup>F-FDG PET study in thyroid carcinoma patients.

Dosimetry-based high-activity therapy with <sup>131</sup>I-metaiodobenzylguanidine (<sup>131</sup>I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma.

Detection of cardiac amyloidosis with <sup>18</sup>F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.

Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.

Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up].

Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.

Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolization.

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines.

Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?